Search hospitals > Michigan > Brighton
University of Michigan - Brighton Center for Specialty Care
Claim this profileBrighton, Michigan 48116
Conducts research for Pancreatic Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
Conducts research for Bladder Cancer
24 reported clinical trials
17 medical researchers
Summary
University of Michigan - Brighton Center for Specialty Care is a medical facility located in Brighton, Michigan. This center is recognized for care of Pancreatic Cancer, Breast Cancer, Breast cancer, Ovarian Cancer, Bladder Cancer and other specialties. University of Michigan - Brighton Center for Specialty Care is involved with conducting 24 clinical trials across 157 conditions. There are 17 research doctors associated with this hospital, such as Vaibhav Sahai, MBBS, MS, Francis P. Worden, Zachery R. Reichert, and Angel Qin.Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
PD-L1 positive
2Breast Cancer
ER positive
HER2 negative
PR positive
Top PIs
Vaibhav Sahai, MBBS, MSUniversity of Michigan Comprehensive Cancer Center6 years of reported clinical research
Studies Pancreatic Cancer
Studies Bile Duct Cancer
16 reported clinical trials
28 drugs studied
Francis P. WordenUniversity of Michigan6 years of reported clinical research
Studies Squamous Cell Carcinoma
Studies Thyroid Cancer
13 reported clinical trials
23 drugs studied
Zachery R. ReichertUniversity of Michigan Comprehensive Cancer Center6 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
10 reported clinical trials
23 drugs studied
Angel QinUniversity of Michigan Comprehensive Cancer Center1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
17 drugs studied
Clinical Trials running at University of Michigan - Brighton Center for Specialty Care
Skin Cancer
Ovarian Cancer
Pancreatic Cancer
Breast Cancer
Bladder Cancer
Breast cancer
Oropharyngeal Carcinoma
Cutaneous Melanoma
Prostate Cancer
Melanoma
Cemiplimab + Surgery
for Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.
Recruiting2 awards Phase 37 criteria
Encorafenib/Binimetinib/Nivolumab vs Ipilimumab/Nivolumab
for Melanoma
This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Ipilimumab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. This trial aims to find out which approach is more effective in shrinking and controlling brain metastases from melanoma.
Recruiting1 award Phase 223 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Michigan - Brighton Center for Specialty Care?
University of Michigan - Brighton Center for Specialty Care is a medical facility located in Brighton, Michigan. This center is recognized for care of Pancreatic Cancer, Breast Cancer, Breast cancer, Ovarian Cancer, Bladder Cancer and other specialties. University of Michigan - Brighton Center for Specialty Care is involved with conducting 24 clinical trials across 157 conditions. There are 17 research doctors associated with this hospital, such as Vaibhav Sahai, MBBS, MS, Francis P. Worden, Zachery R. Reichert, and Angel Qin.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.